Clinical Trials Directory

Trials / Completed

CompletedNCT02043717

Increased Vitamin D Reduces Pulmonary Exacerbations in CF

Increasing Vitamin D Serum Levels Reduces Pulmonary Exacerbations in Patients With Cystic Fibrosis

Status
Completed
Phase
Study type
Observational
Enrollment
90 (actual)
Sponsor
Hadassah Medical Organization · Academic / Other
Sex
All
Age
4 Years
Healthy volunteers
Not accepted

Summary

The investigators study is designed to test the hypothesis that correction of vitamin D in CF patients can increase their lung function and decrease the number of their pulmonary exacerbations.

Detailed description

Vitamin D deficiency is a known problem in CF patients. The CF Foundation Committee published in April 2012 new guidelines for administering vitamin D in CF patients. The investigators' study is designed to look for association between normal serum vitamin D levels and lung function. \~100 CF patients from The Center of Chronic Diseases in Hadassah Medical Organization will be treated according to the new guidelines, and their lung function will be tested once a month during the trial, which will be held for at least one year. In this study, the investigators' goal is to test the efficiency of the new guidelines in correcting serum vitamin D levels, and to follow other related factors such as growth indices (height, weight, BMI), bone mineral density, number of pulmonary exacerbations and number of hospital admissions.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTVitamin DSupplementing oral cholecalciferol according to the new guidelines by: Tangpricha V, Kelly a, Stephenson a, Maguiness K, Enders J, Robinson K a, et al. An update on the screening, diagnosis, management, and treatment of vitamin D deficiency in individuals with cystic fibrosis: evidence-based recommendations from the Cystic Fibrosis Foundation. The Journal of clinical endocrinology and metabolism \[Internet\]. 2012 May \[cited 2012 Oct 31\];97(4):1082-93. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22399505

Timeline

Start date
2014-01-01
Primary completion
2015-01-01
Completion
2015-06-01
First posted
2014-01-23
Last updated
2017-06-27

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT02043717. Inclusion in this directory is not an endorsement.